ADVERSE EVENTS AND LONG-TERM SAFETY OF TREATMENTS IN AUTOINFLAMMATORY DISEASES: REAL
LIFE DATA FROM THE EUROFEVER REGISTRY Yulia Vyzhga, Joost Frenkel, Antonella Insalaco, Jordi Anton , Isabelle Koné-Paut, Elizabeth Legger, Giovanna Fabio, Marco Cattalini, Sylvia Kamphuis, Eric Hachulla, Karoline Krause11, Zelal Ekinci, Judith Sanchez Manubens, J.Merlijn Van den Berg, Cristina Herrera Mora, Petra Hissink Muller , Eztizen Labrador, Judith Potjewijd, Luca Carlini, Marta Bustaffa, Roberta Caorsi, Nicolino Ruperto, Marco Gattorno for Eurofever and the Paediatric Rheumatology International Trials Organisation (PRINTO) J CLIN IMMUNOL - 2024
Fièvre Méditerranéenne Familiale : nouveaux phénotypes et mécanismes génétiques Martin Broly, Guilaine Boursier, Isabelle Touitou* BULL ACAD NATL MED - 2023
Maladies auto-inflammatoires de l’enfant : apport de la génétique Guilaine Boursier, Isabelle Touitou REV PRAT - 2023
A comparative clinical trial to assess a standardized escalation dose strategy of interleukin-1 blockade in Kawasaki disease: The ANACOMP trial Koné-Paut I, Toumazi A, Bourmaud A CLIN INVESTIG (LOND) - 2021
Functional diversity of NLRP3 gain-of-function mutants associated with CAPS autoinflammation. Cosson C, Riou R, Patoli D, Niu T, Rey A, Groslambert M, De Rosny C, Chatre E, Allatif O, Henry T, Venet F, Milhavet F, Boursier G, Belot A, Jamilloux Y, Merlin E, Duquesne A, Grateau G, Savey L, Jacques Maria AT, Pagnier A, Poutrel S, Lambotte O, Mallebranche C, Ardois S, Richer O, Lemelle I, Rieux-Laucat F, Bader-Meunier B, Amoura Z, Melki I, Cuisset L, Touitou I, Geyer M, Georgin-Lavialle S, Py BF. J Exp Med, 2024 May 6. doi: 10.1084/jem.20231200. Epub 2024 Mar 26.
